159 related articles for article (PubMed ID: 7855794)
1. Antithrombotic effects of recombinant human soluble thrombomodulin in a rat model of vascular shunt thrombosis.
Ono M; Nawa K; Marumoto Y
Thromb Haemost; 1994 Sep; 72(3):421-5. PubMed ID: 7855794
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against human thrombomodulin whose epitope is located in epidermal growth factor-like domains.
Nawa K; Ono M; Fujiwara H; Sugiyama N; Uchiyama T; Marumoto Y
Biochim Biophys Acta; 1994 Apr; 1205(2):162-70. PubMed ID: 7512385
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats.
Uchiba M; Okajima K; Murakami K; Nawa K; Okabe H; Takatsuki K
Thromb Haemost; 1995 Nov; 74(5):1265-70. PubMed ID: 8607107
[TBL] [Abstract][Full Text] [Related]
4. The glycosaminoglycan of recombinant human soluble thrombomodulin affects antithrombotic activity in a rat model of tissue factor-induced disseminated intravascular coagulation.
Nawa K; Itani T; Ono M; Sakano K; Marumoto Y; Iwamoto M
Thromb Haemost; 1992 Mar; 67(3):366-70. PubMed ID: 1322570
[TBL] [Abstract][Full Text] [Related]
5. Soluble thrombomodulin is antithrombotic in the presence of neutralising antibodies to protein C and reduces circulating activated protein C levels in primates.
Tanaka KA; Fernández JA; Marzec UM; Kelly AB; Mohri M; Griffin JH; Hanson SR; Gruber A
Br J Haematol; 2006 Jan; 132(2):197-203. PubMed ID: 16398653
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic activity in vivo of SDZ 217-766, a low-molecular weight thrombin inhibitor in comparison to heparin.
Tapparelli C; Metternich R; Gfeller P; Gafner B; Powling M
Thromb Haemost; 1995 Apr; 73(4):641-7. PubMed ID: 7495072
[TBL] [Abstract][Full Text] [Related]
7. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
[TBL] [Abstract][Full Text] [Related]
8. The characterisation of thrombus development in an improved model of arterio-venous shunt thrombosis in the rat and the effects of recombinant desulphatohirudin (CGP 39393), heparin, and iloprost.
Peters RF; Lees CM; Mitchell KA; Tweed MF; Talbot MD; Wallis RB
Thromb Haemost; 1991 Mar; 65(3):268-74. PubMed ID: 1710836
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic effects of recombinant human soluble thrombomodulin (rhs-TM) on arteriovenous shunt thrombosis in rats.
Aoki Y; Takei R; Mohri M; Gonda Y; Gomi K; Sugihara T; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Am J Hematol; 1994 Nov; 47(3):162-6. PubMed ID: 7942778
[TBL] [Abstract][Full Text] [Related]
10. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
11. [Antithrombotic effect of recombinant human thrombomodulin on experimentally induced thrombosis in rats].
Shinmyozu K; Maruyama I
Rinsho Ketsueki; 1991 May; 32(5):497-503. PubMed ID: 1651429
[TBL] [Abstract][Full Text] [Related]
12. Nonpeptide factor Xa inhibitors: I. Studies with SF303 and SK549, a new class of potent antithrombotics.
Wong PC; Quan ML; Crain EJ; Watson CA; Wexler RR; Knabb RM
J Pharmacol Exp Ther; 2000 Jan; 292(1):351-7. PubMed ID: 10604970
[TBL] [Abstract][Full Text] [Related]
13. [The antithrombotic action of a protein C activator from the venom of Agkistrodon blomhoffi ussuriensis in thrombus formation in an extracorporeal shunt in rats].
Kogan AE; Bashkov GV; Bobruskin ID; Romanova EP; Makarov VA; Strukova SM
Eksp Klin Farmakol; 1994; 57(2):42-5. PubMed ID: 8205048
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma.
Ohishi R; Watanabe N; Aritomi M; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Thromb Haemost; 1993 Sep; 70(3):423-6. PubMed ID: 8259542
[TBL] [Abstract][Full Text] [Related]
15. Recombinant desulphatohirudin (CGP 39393) anticoagulant and antithrombotic properties in vivo.
Talbot MD; Ambler J; Butler KD; Findlay VS; Mitchell KA; Peters RF; Tweed MF; Wallis RB
Thromb Haemost; 1989 Feb; 61(1):77-80. PubMed ID: 2749592
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of a novel series of aprotinin-derived anticoagulants. II. Comparative antithrombotic effects on primary thrombus formation in vivo.
Stassen JM; Lambeir AM; Vreys I; Deckmyn H; Matthyssens G; Nyström A; Vermylen J
Thromb Haemost; 1995 Aug; 74(2):655-9. PubMed ID: 8585002
[TBL] [Abstract][Full Text] [Related]
17. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.
Wang YX; Wu C; Vincelette J; Martin-McNulty B; Alexander S; Larsen B; Light DR; McLean K
Thromb Haemost; 2006 Sep; 96(3):317-24. PubMed ID: 16953273
[TBL] [Abstract][Full Text] [Related]
18. Dual effects of sulfated D-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation.
Farias WR; Nazareth RA; Mourão PA
Thromb Haemost; 2001 Dec; 86(6):1540-6. PubMed ID: 11776325
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist.
Berry CN; Lorrain J; Lochot S; Delahaye M; Lalé A; Savi P; Lechaire I; Ferrari P; Bernat A; Schaeffer P; Janiak P; Duval N; Grosset A; Herbert JM; O'Connor SE
Thromb Haemost; 2001 Mar; 85(3):521-8. PubMed ID: 11307825
[TBL] [Abstract][Full Text] [Related]
20. [Thrombomodulin].
Ohmori Y; Takahashi Y
Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):283-9. PubMed ID: 11215378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
